Indivior PLC is a global leader in the development, manufacture, and commercialization of innovative treatments for opioid dependence and related disorders, leveraging its expertise in buprenorphine-based pharmaceuticals. Headquartered in North Chesterfield, Virginia, the company is committed to improving patient outcomes and reducing the impact of addiction through its advanced therapeutic solutions. With a strong focus on research and development, Indivior continues to innovate within the healthcare landscape, aiming to provide effective treatment options that address the complex challenges of opioid use disorder.